You have read all your free articles, to continue reading subscribe to read the rest of this content.
Elicera Therapeutics has announced that Vinnova has granted the company and its project partners 5 million SEK in grants to develop an automated process for CAR T-cell manufacturing. Elicera Therapeutics and its collaborators at Karolinska Institute and their production unit, Vecura at KarolinskaAlready a subscriber Login You have read all…
Cantargia, a private biopharmaceutical company developing therapeutics for the treatment of leukemia has announced the conclusion of the first step in their financial plan and reinforces the board. Sven Andréasson has been appointed as chairman of the board. Sven Andréasson has extensive experiAlready a subscriber Login You have read all…
Finnish Industry Investment half-year report 2016 shows a record-high investment volume – €100 million to finance company growth. “Our investment volume in the first half of 2016 was record-high: we made new investments and commitments amounting to over €100 million. Significant events inAlready a subscriber Login You have read all…
The Swedish biotechnology company Gradientech has closed a fully subscribed rights issue totalling USD 4.6 million (SEK 42.5 million). Existing owners, as well as new parties appointed by Erik Penser Bank AB, who acted as financial advisor, have subscribed. Bird & Bird Lawyers acted as legal Already a subscriber Login…
